Diabetes Genetics: Heredity's Role in Type 1 and Type 2 Risk

Genetics significantly influence diabetes susceptibility, but the architecture differs between types:

Type 1 Diabetes (T1D)

  • Polygenic: >50 loci; strongest association with HLA-DR3/DR4-DQ8 haplotypes (chromosome 6).
  • Concordance: ~50% in identical twins; ~6% in siblings.
  • Mechanism: Autoimmune β-cell destruction triggered by environmental factors (viruses, diet, microbiome) in genetically prone individuals.

Type 2 Diabetes (T2D)

  • Highly Polygenic: >400 loci (TCF7L2, PPARG, KCNJ11, etc.); each confers small risk (OR 1.1–1.3).
  • Heritability: 40–70%; concordance ~70–90% in identical twins.
  • Mechanism: Variants affect insulin secretion, insulin action, adipocyte function, incretin signaling.

Clinical Utility

  • Genetic testing not routine for T1D/T2D diagnosis.
  • Monogenic diabetes (MODY, neonatal diabetes) is diagnosed via genetic testing—impacts treatment (e.g., sulfonylureas for HNF1A/4A MODY).
  • Polygenic risk scores emerging for risk stratification but not yet standard of care.

Family history remains the most practical clinical genetic tool.

Genetic Disorders - Related Articles